Evercore ISI raised the firm’s price target on Hinge Health (HNGE) to $65 from $60 and keeps an Outperform rating on the shares as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earnings season.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HNGE:
- Strong Buy Recommendation for Hinge Health, Inc. Amid Market Underestimation and Strategic Growth Potential
- Hinge Health price target raised to $67 from $57 at Morgan Stanley
- Hinge Health: Strong Buy Rating Driven by AI Innovation and Operational Efficiency
- Hinge Health price target raised to $66 from $63 at Stifel
- Hinge Health initiated with a Neutral at Baird